
Safety Monitoring of COVID-19 mRNA Vaccine First Booster Doses Among Persons Aged ≥12 Years with Presumed Immunocompromise Status - United States, January 12, 2022-March 28, 2022
Published on July 14, 2022
This report describes safety of the COVID-19 mRNA vaccine among immunocompromised persons 12 years or older.
